\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ had\\ subsequent\\ penile\\ revascularization\\ surgery\\ to\\ correct\\ for\\ erectile\\ dysfunction\\.\ \(0\)\
\-\ the\\ paired\\ dorsal\\ arteries\\ and\\ cavernosal\\ arteries\\ of\\ the\\ penis\\ arise\\ from\\ the\\ internal\\ pudendal\\ arteries\\ bilaterally\\.\\ \\ the\\ cavernosal\\ branches\\ are\\ inferior\\ to\\ the\\ dorsal\\ branches\\ and\\ somewhat\\ smaller\\ in\\ caliber\\.\\ \\ \ \(0\)\
\-\ in\\ this\\ patient\\ selective\\ arteriograms\\ of\\ the\\ internal\\ pudendal\\ arteries\\ demonstrates\\ congenital\\ abscence\\ of\\ the\\ right\\ cavernosal\\ artery\\.\\ \\ notice\\ that\\ the\\ right\\ dorsal\\ artery\\ of\\ the\\ penis\\ is\\ hypertrophied\\ to\\ help\\ compensate\\ for\\ limited\\ blood\\ flow\\ to\\ the\\ right\\ crura\\ of\\ the\\ penis\\.\ \(0\)\
\-\ congenital\\ absence\\ of\\ the\\ right\\ cavernosal\\ artery\\ causing\\ erectile\\ dysfunction\ \(0\)\
\-\ congenital\\ absence\\ of\\ the\\ right\\ cavernosal\\ artery\\ \ \(0\)\
\-\ post\\ traumatic\\ occlusion\\ of\\ the\\ right\\ cavernosal\\ artery\\ \ \(0\)\
\-\ thrombosis\\ of\\ or\\ embolization\\ to\\ the\\ right\\ cavernosal\\ artery\\ \ \(0\)\
\-\ vasculidity\\ or\\ vasculopathy\\ affecting\\ the\\ right\\ cavernosal\\ artery\ \(0\)\
\-\ 36\\ year\\ old\\ african\\ american\\ male\\ with\\ long\\ history\\ of\\ difficulty\\ attaining\\ a\\ penile\\ erection\\ without\\ medications\\.\ \(0\)\
\-\ patient\\ demonstrated\\ erectile\\ dysfunction\\ secondary\\ compromised\\ arterial\\ inflow\\.\\ \\ young\\ patients\\ are\\ amenable\\ to\\ penile\\ revascularization\\ with\\ a\\ subjective\\ effectiveness\\ of\\ 40\\-85\\%\\.\ \(0\)\
\-\ kawanishi\\,\\ y\\,\\ kimura\\,\\ k\\,\\ nakanishi\\,\\ r\\,\\ kojima\\,\\ k\\,\\ and\\ numata\\,\\ a\\.\\ \\ \\"penile\\ revasculariztaion\\ surgery\\ for\\ arteriogenic\\ erectile\\ dysfunction\\:\\ \\ the\\ long\\ term\\ efficacy\\ rate\\ calculated\\ by\\ survival\\ analysis\\"\\.\\ \\ bju\\ international\\.\\ \\ volume\\ 94\\.\\ \\ issue\\ 3\\.\\ \\ august\\ 2004\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cavernosal\\:\\ 0\\.592005964890746\ \(0\)\
\-\ erectile\\:\\ 0\\.2786569961933687\ \(0\)\
\-\ penile\\:\\ 0\\.2518835339845986\ \(0\)\
\-\ artery\\:\\ 0\\.2105279494470979\ \(0\)\
\-\ dysfunction\\:\\ 0\\.18808655170148703\ \(0\)\
\-\ penis\\:\\ 0\\.18465818812238935\ \(0\)\
\-\ the\\:\\ 0\\.16426470033871063\ \(0\)\
\-\ pudendal\\:\\ 0\\.15488563315262766\ \(0\)\
\-\ arteries\\:\\ 0\\.1537358561018312\ \(0\)\
\-\ dorsal\\:\\ 0\\.13400502774097275\ \(0\)\
\-\ revascularization\\:\\ 0\\.13134859643162677\ \(0\)\
\-\ right\\:\\ 0\\.1284402890048728\ \(0\)\
\-\ congenital\\:\\ 0\\.1043823977026357\ \(0\)\
\-\ of\\:\\ 0\\.1042430812373687\ \(0\)\
\-\ branches\\:\\ 0\\.09604304135012542\ \(0\)\
\-\ crura\\:\\ 0\\.07744281657631383\ \(0\)\
\-\ vasculidity\\:\\ 0\\.07744281657631383\ \(0\)\
\-\ erection\\:\\ 0\\.07744281657631383\ \(0\)\
\-\ kawanishi\\:\\ 0\\.07744281657631383\ \(0\)\
\-\ nakanishi\\:\\ 0\\.07744281657631383\ \(0\)\
\-\ kojima\\:\\ 0\\.07744281657631383\ \(0\)\
\-\ numata\\:\\ 0\\.07744281657631383\ \(0\)\
\-\ revasculariztaion\\:\\ 0\\.07744281657631383\ \(0\)\
\-\ arteriogenic\\:\\ 0\\.07744281657631383\ \(0\)\
\-\ absence\\:\\ 0\\.07721443769164575\ \(0\)\
\-\ attaining\\:\\ 0\\.07400074561134325\ \(0\)\
\-\ bju\\:\\ 0\\.07400074561134325\ \(0\)\
\-\ to\\:\\ 0\\.07263758529722464\ \(0\)\
\-\ arteriograms\\:\\ 0\\.07155855739606361\ \(0\)\
\-\ compensate\\:\\ 0\\.07155855739606361\ \(0\)\
\-\ paired\\:\\ 0\\.06966424904834218\ \(0\)\
\-\ kimura\\:\\ 0\\.06966424904834218\ \(0\)\
\-\ vasculopathy\\:\\ 0\\.06811648643109301\ \(0\)\
\-\ inflow\\:\\ 0\\.06811648643109301\ \(0\)\
\-\ abscence\\:\\ 0\\.06567429821581339\ \(0\)\
\-\ internal\\:\\ 0\\.06527178054227432\ \(0\)\
\-\ amenable\\:\\ 0\\.06467441546612242\ \(0\)\
\-\ long\\:\\ 0\\.06422210250101912\ \(0\)\
\-\ effectiveness\\:\\ 0\\.06377998986809195\ \(0\)\
\-\ calculated\\:\\ 0\\.06033791890312137\ \(0\)\
\-\ efficacy\\:\\ 0\\.0587901562858722\ \(0\)\
\-\ international\\:\\ 0\\.0587901562858722\ \(0\)\
\-\ compromised\\:\\ 0\\.05833116928854613\ \(0\)\
\-\ issue\\:\\ 0\\.057895730687841734\ \(0\)\
\-\ selective\\:\\ 0\\.05748154163900513\ \(0\)\
\-\ notice\\:\\ 0\\.056347968070592565\ \(0\)\
\-\ subjective\\:\\ 0\\.0560014223401203\ \(0\)\
\-\ hypertrophied\\:\\ 0\\.05445365972287114\ \(0\)\
\-\ august\\:\\ 0\\.05290589710562198\ \(0\)\
\-\ surgery\\:\\ 0\\.05207112661919679\ \(0\)\
\-\ correct\\:\\ 0\\.05082500560895469\ \(0\)\
\-\ caliber\\:\\ 0\\.05082500560895469\ \(0\)\
\-\ affecting\\:\\ 0\\.048712079389221466\ \(0\)\
\-\ survival\\:\\ 0\\.047260785895753846\ \(0\)\
\-\ patient\\:\\ 0\\.047251091277177935\ \(0\)\
\-\ 2004\\:\\ 0\\.04561255830078321\ \(0\)\
\-\ analysis\\:\\ 0\\.04503352540179167\ \(0\)\
\-\ help\\:\\ 0\\.0444914780260731\ \(0\)\
\-\ occlusion\\:\\ 0\\.0444914780260731\ \(0\)\
\-\ arise\\:\\ 0\\.04431822320570801\ \(0\)\
\-\ somewhat\\:\\ 0\\.04406479568353404\ \(0\)\
\-\ for\\:\\ 0\\.044032135236155304\ \(0\)\
\-\ african\\:\\ 0\\.04373824805780729\ \(0\)\
\-\ smaller\\:\\ 0\\.04357956696040116\ \(0\)\
\-\ volume\\:\\ 0\\.04254482095210665\ \(0\)\
\-\ embolization\\:\\ 0\\.04220384373055077\ \(0\)\
\-\ american\\:\\ 0\\.04131610516834355\ \(0\)\
\-\ difficulty\\:\\ 0\\.040734426218823734\ \(0\)\
\-\ medications\\:\\ 0\\.040622724718563444\ \(0\)\
\-\ 36\\:\\ 0\\.040085254651866555\ \(0\)\
\-\ young\\:\\ 0\\.03993043227795352\ \(0\)\
\-\ arterial\\:\\ 0\\.039879445989320625\ \(0\)\
\-\ causing\\:\\ 0\\.03977838299169551\ \(0\)\
\-\ thrombosis\\:\\ 0\\.03948221836778219\ \(0\)\
\-\ limited\\:\\ 0\\.03865109073436393\ \(0\)\
\-\ term\\:\\ 0\\.03797497702813172\ \(0\)\
\-\ are\\:\\ 0\\.03675050219955275\ \(0\)\
\-\ traumatic\\:\\ 0\\.03669542503045998\ \(0\)\
\-\ rate\\:\\ 0\\.03669542503045998\ \(0\)\
\-\ subsequent\\:\\ 0\\.03666056177185642\ \(0\)\
\-\ or\\:\\ 0\\.033692694746844026\ \(0\)\
\-\ inferior\\:\\ 0\\.03294462216831327\ \(0\)\
\-\ bilaterally\\:\\ 0\\.03229627732303359\ \(0\)\
\-\ flow\\:\\ 0\\.03225476530125001\ \(0\)\
\-\ and\\:\\ 0\\.030019571275803125\ \(0\)\
\-\ demonstrated\\:\\ 0\\.02976097089945567\ \(0\)\
\-\ secondary\\:\\ 0\\.02870297789420864\ \(0\)\
\-\ blood\\:\\ 0\\.028123645521144384\ \(0\)\
\-\ patients\\:\\ 0\\.027241956897054158\ \(0\)\
\-\ post\\:\\ 0\\.02634982598522192\ \(0\)\
\-\ without\\:\\ 0\\.025542597545272366\ \(0\)\
\-\ demonstrates\\:\\ 0\\.024328413143923044\ \(0\)\
\-\ had\\:\\ 0\\.024127333360825485\ \(0\)\
\-\ in\\:\\ 0\\.024093354417609767\ \(0\)\
\-\ male\\:\\ 0\\.02156086755322423\ \(0\)\
\-\ that\\:\\ 0\\.021014823782037118\ \(0\)\
\-\ by\\:\\ 0\\.020564249249464157\ \(0\)\
\-\ from\\:\\ 0\\.019232530691431177\ \(0\)\
\-\ with\\:\\ 0\\.01896461208246696\ \(0\)\
\-\ history\\:\\ 0\\.018501320452687698\ \(0\)\
\-\ this\\:\\ 0\\.016639852345296868\ \(0\)\
\-\ year\\:\\ 0\\.014923766376887367\ \(0\)\
\-\ old\\:\\ 0\\.01433198171174541\ \(0\)\
\-\ is\\:\\ 0\\.013261635021961489\ \(0\)\
